Therapy Areas: Allergy
13 September 2018 - - US-based biotechnology vaccines developer TechnoVax, Inc has received a two-year USD 1.481m SBIR-II grant from the National Institute of Allergy and Infectious Diseases (NIAID) o...
13 September 2018 - Health care company Bayer Animal Health GmbH said on Wednesday that it plans to advance innovative allergy treatment options for companion animals under a global license agreement ...
12 September 2018 - - US-based small molecule drug developer DesignMedix's lead product, experimental anti-malaria medicine DM1157, has begun human clinical trials, the company said.

...
10 September 2018 - - US-based biotechnology company Immunomic Therapeutics, Inc has appointed immuno-oncology expert Richard Ambinder, M.D., Ph.D., director, Division of Hematologic Malignancies at J...
5 September 2018 - - US-based drug delivery platform developer Mati Therapeutics Inc. has completed a planned interim analysis of an ongoing Phase II clinical trial evaluating the safety and efficacy ...
5 September 2018 - - US-based biopharmaceutical company Soligenix, Inc. (NASDAQ : SNGX) has published extended stability studies for RiVax showing up to 100% protection in mice even after 12...